EDWARDS LIFESCIENCES ($EW) posted quarterly earnings results for Q2 2026 on Thursday, July 23rd. The company reported earnings of $0.78 per share, beating estimates of $0.76 by $0.02. The company also reported revenue of $1,741,000,000, missing estimates of $1,751,169,280 by $-10,169,280.
Stock price change since market close: +1.31%
You can see Quiver Quantitative's $EW stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EDWARDS LIFESCIENCES Insider Trading Activity
EDWARDS LIFESCIENCES insiders have traded $EW stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $EW stock by insiders over the last 6 months:
- DONALD E JR BOBO (CVP,Strategy/Corp Development) has made 0 purchases and 7 sales selling 99,133 shares for an estimated $8,277,433.
- SCOTT B. ULLEM (CVP, Chief Financial Officer) has made 0 purchases and 4 sales selling 26,000 shares for an estimated $2,144,440.
- BERNARD J ZOVIGHIAN (CEO) has made 0 purchases and 3 sales selling 22,953 shares for an estimated $1,765,723.
- DANIEL J. LIPPIS (CVP, TAVR) has made 0 purchases and 8 sales selling 5,934 shares for an estimated $503,333.
- DAVEEN CHOPRA (CVP, TMTT & Surgical) sold 1,500 shares for an estimated $126,905
- ANDREW M. DAHL (SVP, Corporate Controller) sold 567 shares for an estimated $48,852
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
EDWARDS LIFESCIENCES Hedge Fund Activity
We have seen 527 institutional investors add shares of EDWARDS LIFESCIENCES stock to their portfolio, and 541 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 5,079,892 shares (+65.7%) to their portfolio in Q1 2026, for an estimated $406,797,751
- MILLENNIUM MANAGEMENT LLC removed 4,284,117 shares (-70.5%) from their portfolio in Q1 2026, for an estimated $343,072,089
- ARTISAN PARTNERS LIMITED PARTNERSHIP added 4,034,429 shares (+345.8%) to their portfolio in Q1 2026, for an estimated $323,077,074
- MARSHALL WACE, LLP removed 3,929,250 shares (-66.3%) from their portfolio in Q1 2026, for an estimated $314,654,340
- BANK OF AMERICA CORP /DE/ added 2,212,208 shares (+132.4%) to their portfolio in Q1 2026, for an estimated $177,153,616
- FMR LLC removed 2,078,777 shares (-12.5%) from their portfolio in Q1 2026, for an estimated $166,468,462
- NEUBERGER BERMAN GROUP LLC added 2,021,413 shares (+614.8%) to their portfolio in Q1 2026, for an estimated $161,874,753
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
EDWARDS LIFESCIENCES Government Contracts
We have seen $27,358,165 of award payments to $EW over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TRANSCATHETER HEART VALVE REPLACEMENT SYSTEMS: $238,000
- CUSTOM SURGICAL IMPLANTS: $204,000
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
EDWARDS LIFESCIENCES Congressional Stock Trading
Members of Congress have traded $EW stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $EW stock by members of Congress over the last 6 months:
- SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
EDWARDS LIFESCIENCES Analyst Ratings
Wall Street analysts have issued reports on $EW in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 06/30/2026
To track analyst ratings and price targets for EDWARDS LIFESCIENCES, check out Quiver Quantitative's $EW forecast page.
EDWARDS LIFESCIENCES Price Targets
Multiple analysts have issued price targets for $EW recently. We have seen 13 analysts offer price targets for $EW in the last 6 months, with a median target of $100.0.
Here are some recent targets:
- Joanne Wuensch from Citigroup set a target price of $110.0 on 07/08/2026
- Vijay Kumar from Evercore ISI Group set a target price of $100.0 on 07/06/2026
- Marie Thibault from BTIG set a target price of $110.0 on 06/30/2026
- Shagun Singh from RBC Capital set a target price of $100.0 on 06/16/2026
- Joshua Jennings from TD Cowen set a target price of $104.0 on 06/02/2026
- Matt Miksic from Barclays set a target price of $110.0 on 04/27/2026
- William Plovanic from Canaccord Genuity set a target price of $85.0 on 04/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
